CN102512540B - Chinese medicine composition for treating asthma - Google Patents

Chinese medicine composition for treating asthma Download PDF

Info

Publication number
CN102512540B
CN102512540B CN2011104377164A CN201110437716A CN102512540B CN 102512540 B CN102512540 B CN 102512540B CN 2011104377164 A CN2011104377164 A CN 2011104377164A CN 201110437716 A CN201110437716 A CN 201110437716A CN 102512540 B CN102512540 B CN 102512540B
Authority
CN
China
Prior art keywords
mass parts
chinese medicine
radix
medicine composition
asthma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2011104377164A
Other languages
Chinese (zh)
Other versions
CN102512540A (en
Inventor
王学峰
柳晖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wang Xuefeng
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011104377164A priority Critical patent/CN102512540B/en
Publication of CN102512540A publication Critical patent/CN102512540A/en
Application granted granted Critical
Publication of CN102512540B publication Critical patent/CN102512540B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a Chinese medicine composition for treating asthma, comprising the following Chinese medicine raw materials: 5-20 mass parts of fried ephedra, 5-20 mass parts of almond, 20-60 mass parts of gypsum, 5-25 mass parts of cortex mori radicis, 5-25 mass parts of cortex lycii radicis, 5-20 mass parts of Radix Scutellariae, 10-30 mass parts of Radix trichosanthis, 10-50 mass parts of honeysuckle, 5-20 mass parts of peach seed, 5-20 mass parts of safflower, 5-20 mass parts of Platycodon grandiflorum, 5-20 mass parts of Perilla seed, 10-40 mass parts of Radix Scrophulariae, and 5-20 mass parts of licorice. The Chinese medicine composition has the outstanding effects of diffusing lung and calming panting, clearing heat and purging fire, strengthening spleen and benefiting qi, and eliminating phlegm and reliving cough, reliable effects, and has the advantages of widespread medicinal herbs resource of the ingredients, simple preparation, mild medical properties, and no toxic and side effect.

Description

A kind of Chinese medicine composition for the treatment of asthma
Technical field
The present invention relates to a kind of not medicinal preparation of definite structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of asthma.
Background technology
Asthma, general common name asthma, be a kind of disease take rapid breathing as feature,, with rapid breathing, even dehisces to shrug, flaring of nares is principal character.Normal is the cardinal symptom of some acute illness, and the rarely seen breathing of the lighter is urged, and breathing is profound, generally still can put down sleeping.The visible flaring of nares of severe one, opening mouth and lifting shoulder due to dyspnea, shake body and pick tripe, orthopnea, face lip cyanosis.If dyspnea with rapid and short breath is serious, continue not understand, can collapse.At present, now changing treatment the syndrome of dyspnea on clinical medicine is mainly that employing medicine inhibition alleviation asthmatic attack is main.For example, use the medicines such as bronchodilator and antitussive, the agent of reducing phlegm.This employing suppresses the Drug therapy asthma can only the respite symptom, does not reach the therapeutic effect of expection.
The traditional Chinese medical science thinks, the syndrome of dyspnea cause of disease is diseases caused by exogenous pathogenic factor and internal injury not, and characteristic of disease has the deficiency and excess two ends." overabundance of pathogen causing excess syndrome, lack of vital essence resulting in deficiency syndrome." diseases caused by exogenous pathogenic factor six climate exopathogens, internal damage by the excessive seven emotions, eating and drinking without temperance, mostly be excess-dyspnea because of; Labor is wanted, prolonged illness is dyspnea due to deficiency by, both can mutually transform: excess-dyspnea prolonged illness protracted course of disease, can consume the gas of impairing the lung kidney, cause insufficiency of QI of the lung and kidney or the deficiency of YIN, the not main gas of lung or failure of the kidney in receiving QI, become dyspnea due to deficiency; Lung deficiency of the kidney void is easily caused again exopathogen invasion and attack, pathogenic factor in the exterior bundle lung, and excess of the lung and breathing heavily, thus the card of simulataneous insufficiency and excessive appears.
Its Therapeutic Principle: excess-dyspnea is controlled lung, controls with eliminating pathogen to activate QI.Should distinguish the difference of cold, hot, expectorant, gas, adopt respectively Wen Xuan, respectful clearly, eliminate the phlegm, the method such as sending down the abnormal ascending QI.Dyspnea due to deficiency is controlled at the lung kidney,, take kidney as main, controls with invigorating kidney QI to promote inspiration.For the pathogenesis of Zong-Fu diseases, adopt tonifying the lung, receive kidney, warming YANG, QI invigorating, yin nourishing, admittedly the method such as take off.Simulataneous insufficiency and excessive, the deficiency in the lower and excess in the upper person, when knowing the secondary from the primary, the balance specimen, suitably process.
, according to theory of Chinese medical science,, for the pathogeny of asthma, carry out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome the deficiency that prior art western medicine asthma can only the respite symptom, the invention provides a kind ofly prepare conveniently, the medicine source is wide, cost is low, evident in efficacy, reliable effect, a kind of Chinese medicine composition for the treatment of asthma of having no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of asthma is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: Herba Ephedrae (processed) 5-20 part, Semen Armeniacae Amarum 5-20 part, Gypsum Fibrosum 20-60 part, Cortex Mori 5-25 part, Cortex Lycii 5-25 part, Radix Scutellariae 5-20 part, Radix Trichosanthis 10-30 part, Flos Lonicerae 10-50 part, Semen Persicae 5-20 part, Flos Carthami 5-20 part, Radix Platycodonis 5-20 part, Fructus Perillae 5-20 part, Radix Scrophulariae 10-40 part, Radix Glycyrrhizae 5-20 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of asthma is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 10 parts of Herba Ephedrae (processed), 10 parts, Semen Armeniacae Amarum, 50 parts, Gypsum Fibrosum, 15 parts of Cortex Mori, 15 parts of Cortex Lycii, 12 parts of Radix Scutellariaes, 20 parts of Radix Trichosanthis, 40 parts of Flos Loniceraes, 10 parts, Semen Persicae, 10 parts, Flos Carthami, 10 parts of Radix Platycodoniss, 10 parts of Fructus Perillaes, 30 parts of Radix Scrophulariae, 10 parts, Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In the present invention in drug composition: Herba Ephedrae (processed) has the effect of relieving the exterior syndrome by diaphoresis, depressed lung-energy dispersing; Semen Armeniacae Amarum has expelling phlegm for arresting cough, the effect of the intestine moistening of relievining asthma, lower air to open numbness; Gypsum Fibrosum has the effect that clearing away heat-fire, relieving restlessness quench the thirst; Cortex Mori has the effect of eliminating pathogen from the lung for relieving asthma; Cortex Lycii has the effect of removing heat from blood except steaming, lung heat clearing pathogenic fire reducing; Radix Scutellariae has the effect of heat clearing and damp drying, eliminating fire and detoxication; Radix Trichosanthis has clearing away heat and promoting production of body fluid, moisturizes the effect of quenching the thirst; Flos Lonicerae has the effect of heat-clearing and toxic substances removing; Semen Persicae has the effect of blood circulation promoting and blood stasis dispelling; Flos Carthami has the effect of the latus rectum of invigorating blood circulation, eliminating stasis to stop pain; Radix Platycodonis has the effect that lung qi dispersing eliminates the phlegm, fosters the spirit of nobility and enrich blood; Fructus Perillae has the sending down the abnormal ascending QI expectorant, relievings asthma, the effect of intestine moistening; Radix Scrophulariae has that yin nourishing removing heat from blood, clearing away heat-fire, relieving restlessness quench the thirst, the effect of detoxicating and resolving stagnation of pathogens; Radix Glycyrrhizae has the effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.Drug component in the present composition is through dialectical compatibility, complements each other using, and has synergism, plays altogether the effect of depressed lung-energy dispersing, clearing away heat-fire, invigorating the spleen and replenishing QI, expelling phlegm for arresting cough, thereby reaches the purpose for the treatment of asthma.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, the medicine source is wide, cost is low.It follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the use that is decocted in water for oral dose.Through the clinical practice checking, it is evident in efficacy, reliable effect, and the property of medicine is gentle, has no side effect, and effective percentage reaches 95.1%, and cure rate reaches 61%.
The specific embodiment
The present invention will be further described below in conjunction with embodiment.
Embodiment 1
A kind of Chinese medicine composition for the treatment of asthma, its raw material of Chinese medicine by following weight proportion forms: Herba Ephedrae (processed) 10g, Semen Armeniacae Amarum 10g, Gypsum Fibrosum 50g, Cortex Mori 15g, Cortex Lycii 15g, Radix Scutellariae 12g, Radix Trichosanthis 20g, Flos Lonicerae 40g, Semen Persicae 10g, Flos Carthami 10g, Radix Platycodonis 10g, Fructus Perillae 10g, Radix Scrophulariae 30g, Radix Glycyrrhizae 10g.
Embodiment 2
A kind of Chinese medicine composition for the treatment of asthma, its raw material of Chinese medicine by following weight proportion forms: Herba Ephedrae (processed) 5g, Semen Armeniacae Amarum 15g, Gypsum Fibrosum 60g, Cortex Mori 20g, Cortex Lycii 25g, Radix Scutellariae 10g, Radix Trichosanthis 10g, Flos Lonicerae 20g, Semen Persicae 15g, Flos Carthami 5g, Radix Platycodonis 15g, Fructus Perillae 20g, Radix Scrophulariae 10g, Radix Glycyrrhizae 12g.
Embodiment 3
A kind of Chinese medicine composition for the treatment of asthma, its raw material of Chinese medicine by following weight proportion forms: Herba Ephedrae (processed) 15g, Semen Armeniacae Amarum 5g, Gypsum Fibrosum 20g, Cortex Mori 25g, Cortex Lycii 10g, Radix Scutellariae 5g, Radix Trichosanthis 30g, Flos Lonicerae 10g, Semen Persicae 20g, Flos Carthami 15g, Radix Platycodonis 20g, Fructus Perillae 5g, Radix Scrophulariae 20g, Radix Glycyrrhizae 15g.
Embodiment 4
A kind of Chinese medicine composition for the treatment of asthma, its raw material of Chinese medicine by following weight proportion forms: Herba Ephedrae (processed) 20g, Semen Armeniacae Amarum 12g, Gypsum Fibrosum 30g, Cortex Mori 5g, Cortex Lycii 20g, Radix Scutellariae 15g, Radix Trichosanthis 25g, Flos Lonicerae 30g, Semen Persicae 5g, Flos Carthami 12g, Radix Platycodonis 12g, Fructus Perillae 15g, Radix Scrophulariae 40g, Radix Glycyrrhizae 5g.
Embodiment 5
A kind of Chinese medicine composition for the treatment of asthma, its raw material of Chinese medicine by following weight proportion forms: Herba Ephedrae (processed) 12g, Semen Armeniacae Amarum 20g, Gypsum Fibrosum 40g, Cortex Mori 10g, Cortex Lycii 5g, Radix Scutellariae 20g, Radix Trichosanthis 15g, Flos Lonicerae 50g, Semen Persicae 12g, Flos Carthami 20g, Radix Platycodonis 5g, Fructus Perillae 12g, Radix Scrophulariae 15g, Radix Glycyrrhizae 20g.
Chinese medicine composition in embodiment of the present invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soaked 15~20 minutes, then add water and do not have approximately 8 centimetres of powder, decoct.Adopt intense fire to decoct at a simmer, boil rear with slow fire boiling 20~30 minutes; Second decocts, the water rear decoction 15~20 minutes of boiling.Twice decoction extracting juice that removes slag, merge.
A kind of Chinese medicine composition for the treatment of asthma, clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to clinical observation case 41 examples, male's 24 examples, women's 17 examples; At 6~70 years old age, the course of disease is the shortest 5 days, and is the longest 3 years.
Two, symptom and sign: the patient many suffering from cold, feelings will is not relaxed, tired after morbidity, with uncomfortable in chest, cough, breathe, gurgling with sputum, very the person can not to put down sleeping be cardinal symptom, and touchingly do not heal, the elder delays the several months, shows effect the short week that also has, outbreak repeatedly, 1 year for several times.
Three, usage and dosage: during clinical practice, the component in compositions, consumption are taken the circumstances into consideration increase and decrease according to patient's body weight, age and symptom.Potion on the one, twice extracting juice of decocting be 300ml approximately, divides early, takes for late twice.Seven days is a course for the treatment of.
Four, criterion of therapeutical effect:
(1) recovery from illness: the symptom such as cough, breathe is eliminated, in 2 years without recurrence;
(2) take a turn for the better: symptom before alleviates, and attack times reduces, and occasionally has morbidity to recover very soon after treatment;
(3) invalid: after treatment, symptom increases the weight of to some extent without improvement or the state of an illness.
Five, therapeutic effect: in this clinical observation case, take medicine 1-10 the course for the treatment of, recovery from illness 25 examples, 14 examples that take a turn for the better, invalid 2 examples.Toxic and side effects does not occur during treatment.
Six, model case:
Case 1:
High certain, man, 62 years old.Medical cause is suffered from cold and is occurred panting, and the glutinous expectorant of white is coughed up in cough, accompanies indigestion and loss of appetite, vomiting and nausea, is in from taking antitussive, and symptom has no improvement.Disease is seen: pant, tachypnea, can not put down sleepingly, and cough, cough up the glutinous expectorant of white, and is indigestion and loss of appetite, and vomiting and nausea is mouthful glutinous thirsty.Pale tongue is fat, and tongue is greasy in vain, rolling pulse.Take 1 course for the treatment of of medicament of Chinese medicine composition preparation of the present invention, the symptoms such as dyspnea with rapid and short breath, cough are obviously alleviated, and the amount of coughing up phlegm reduces; Continue and take 2 courses for the treatment of, all transference cures, cure.
Case 2:
Yuan, man, 69 years old.Medical private prosecution: recurrent cough, expectoration are had a surplus half a year, in the recent period outbreak companion dyspnea with rapid and short breath.Disease is seen: Mental fatigue, cough, dyspnea with rapid and short breath, must not put down sleeping, exhale inhale few, moving breathe heavily very die Blausucht, cardiopalmus, sweating, cold extremities, the few tongue of red tongue, thready and rapid pulse.Take 2 courses for the treatment of of medicament of Chinese medicine composition of the present invention preparation, symptom is alleviated to some extent, feels still that dyspnea with rapid and short breath is more than, cardiopalmus; Continuous take 2 courses for the treatment of, the diseases such as uncomfortable in chest, dyspnea with rapid and short breath, dyspnea obviously alleviate; Renew and take 2 courses for the treatment of, the symptom such as cough, breathe is eliminated, spiritual amelioration.

Claims (1)

1. Chinese medicine composition for the treatment of asthma, it is characterized in that: its raw material of Chinese medicine and weight proportion are: Herba Ephedrae (processed) 10g, Semen Armeniacae Amarum 10g, Gypsum Fibrosum 50g, Cortex Mori 15g, Cortex Lycii 15g, Radix Scutellariae 12g, Radix Trichosanthis 20g, Flos Lonicerae 40g, Semen Persicae 10g, Flos Carthami 10g, Radix Platycodonis 10g, Fructus Perillae 10g, Radix Scrophulariae 30g, Radix Glycyrrhizae 10g.
CN2011104377164A 2011-12-23 2011-12-23 Chinese medicine composition for treating asthma Expired - Fee Related CN102512540B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011104377164A CN102512540B (en) 2011-12-23 2011-12-23 Chinese medicine composition for treating asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011104377164A CN102512540B (en) 2011-12-23 2011-12-23 Chinese medicine composition for treating asthma

Publications (2)

Publication Number Publication Date
CN102512540A CN102512540A (en) 2012-06-27
CN102512540B true CN102512540B (en) 2013-11-13

Family

ID=46283793

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011104377164A Expired - Fee Related CN102512540B (en) 2011-12-23 2011-12-23 Chinese medicine composition for treating asthma

Country Status (1)

Country Link
CN (1) CN102512540B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104324209B (en) * 2014-10-21 2017-09-15 张其星 One kind treats snorting Chinese medicine composition of pig and preparation method thereof
CN105031140A (en) * 2015-09-14 2015-11-11 宋晓梅 Traditional Chinese medicine preparation for treating asthma and preparing method thereof
CN105381437A (en) * 2015-12-15 2016-03-09 马凯 Traditional Chinese medicine decoction for treating asthma
CN105535739A (en) * 2016-01-22 2016-05-04 青岛市市立医院 Traditional Chinese medicine preparation for treating phlegm-heat excessive accumulation type chronic cough

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101780238A (en) * 2010-04-20 2010-07-21 泰一和浦(北京)中医药研究院有限公司 Traditional Chinese medicine composition for treating asthma and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101780238A (en) * 2010-04-20 2010-07-21 泰一和浦(北京)中医药研究院有限公司 Traditional Chinese medicine composition for treating asthma and preparation method thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
冯丽丽等.中医药治疗小儿肺炎临床研究进展.《湖南中医药导报》.2004,第10卷(第09期),63-64、68. *
吴倩茹等.支气管哮喘发生机理及中医药疗法的研究进展.《浙江中医学院学报》.2000,第24卷(第05期),75-77. *
小儿肺炎喘嗽中医诊疗指南;汪受传等;《中医儿科杂志》;20080515;第4卷(第03期);1-3 *
汪受传等.小儿肺炎喘嗽中医诊疗指南.《中医儿科杂志》.2008,第4卷(第03期),1-3.
赵霞等.小儿肺炎中医药研究进展.《中医药研究》.2000,第16卷(第04期),57-59. *

Also Published As

Publication number Publication date
CN102512540A (en) 2012-06-27

Similar Documents

Publication Publication Date Title
CN101766782B (en) Chinese medicine composite for treating chronic gastritis and preparation method thereof
CN102743737B (en) Chinese medicinal preparation for effectively treating tracheitis
CN103920106A (en) Traditional Chinese medicinal composition for treating bronchitis and bronchial asthma
CN103550729B (en) A kind of Chinese medicine composition for the treatment of cough
CN103536758B (en) Traditional Chinese medicinal composition for treating night sweat due to yin deficiency
CN103536889B (en) One is treated senile chronic tracheitis and is merged emophysematous Chinese medicine decoction
CN104013864A (en) Traditional Chinese medicine composition for treating bronchitis
CN101972443B (en) Chinese medicinal formula for treating chronic gastritis
CN103393879A (en) Traditional Chinese medicine composition for treating liver and kidney deficiency
CN101810792B (en) Chinese medicinal composition for treating kidney failure diseases and preparation method thereof
CN102430072B (en) Traditional Chinese medicine composite for treating cough
CN102512540B (en) Chinese medicine composition for treating asthma
CN103330826B (en) Traditional Chinese medicine composition for treating deficiency of lung yin
CN101647979B (en) Traditional Chinese medicine for treating bronchial asthma
CN102988735A (en) Chinese medicament composition for treating cough
CN104800549A (en) Traditional Chinese medicine composition for treating chronic bronchitis
CN103721082A (en) Traditional Chinese medicinal composition for treating scapulohumeral periarthritis
CN103341063A (en) Chinese medicine composition for treating wind-heat cough
CN103495130B (en) Traditional Chinese medicine composition for treating asthma
CN103142965A (en) Traditional Chinese medicine preparation for treating cold drink type children bronchial asthma
CN103212039B (en) Traditional Chinese medicine composition for treating infantile cough caused by qi deficiency
CN104758884A (en) Traditional Chinese medicine composition for treating asthma
CN103550642A (en) Traditional Chinese medicine composition for treating wind-warm lung-heat disease caused by wind-heat affecting lung
CN103212013A (en) Chinese medicinal composition for treating epigastric pain
CN102284023A (en) Chinese medicinal composition for treating asthma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: WANG XUEFENG

Free format text: FORMER OWNER: RONGCHENG YATOU MEIQUAN DENTAL CLINIC

Effective date: 20131022

C14 Grant of patent or utility model
C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Wang Xuefeng

Inventor after: Liu Hui

Inventor before: Liu Hui

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 264300 WEIHAI, SHANDONG PROVINCE TO: 264500 WEIHAI, SHANDONG PROVINCE

Free format text: CORRECT: INVENTOR; FROM: LIU HUI TO: WANG XUEFENG LIU HUI

GR01 Patent grant
TA01 Transfer of patent application right

Effective date of registration: 20131022

Address after: 264500 No. 128 Shengli Street, Weihai, Shandong, Rushan

Applicant after: Wang Xuefeng

Address before: 264300, No. 91, building No. 11, lotus pond North District, Weihai City, Shandong, Rongcheng

Applicant before: Rongcheng Yatou Meiquan Dental Clinic

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131113

Termination date: 20141223

EXPY Termination of patent right or utility model